Role of diffusion-weighted imaging in monitoring treatment response following high-intensity focused ultrasound ablation of recurrent sacral chordoma.

Autor:	Chetan MR; Nuffield Department of Surgical Sciences, University of Oxford, Room 6607, Level 6, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK.; Department of Radiology, Churchill Hospital, Old Road, Oxford, OX3 7LE, UK., Lyon PC; HIFU Unit, Churchill Hospital, Old Road, Oxford, OX3 7LE, UK.; Department of Radiology, Churchill Hospital, Old Road, Oxford, OX3 7LE, UK., Wu F; Nuffield Department of Surgical Sciences, University of Oxford, Room 6607, Level 6, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK.; HIFU Unit, Churchill Hospital, Old Road, Oxford, OX3 7LE, UK., Phillips R; Department of Radiology, Churchill Hospital, Old Road, Oxford, OX3 7LE, UK., Cranston D; Nuffield Department of Surgical Sciences, University of Oxford, Room 6607, Level 6, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK., Gillies MJ; Nuffield Department of Surgical Sciences, University of Oxford, Room 6607, Level 6, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU, UK.; Department of Neurosurgery, John Radcliffe Hospital, Headley Way, Oxford, UK., Bojanic S; Department of Neurosurgery, John Radcliffe Hospital, Headley Way, Oxford, UK.
Jazyk:	angličtina
Zdroj:	Radiology case reports [Radiol Case Rep] 2019 Aug 01; Vol. 14 (10), pp. 1197-1201. Date of Electronic Publication: 2019 Aug 01 (Print Publication: 2019).
DOI:	10.1016/j.radcr.2019.07.004
Abstrakt:	Chordoma is the most common malignant tumor of the sacrum and is associated with significant neurologic morbidity. Local recurrence is very common, and the long-term prognosis is poor. High-intensity focused ultrasound (HIFU) is a noninvasive and nonionising ablative therapy that has been successful in treating other tumor types and is being evaluated as a new therapy for sacral chordoma. Contrast-enhanced magnetic resonance imaging is typically used to evaluate tumor perfusion following HIFU; however, its utility is limited in poorly perfused tumors. Diffusion-weighted imaging (DWI) provides tissue contrast based on differences in the diffusion of extracellular water without using gadolinium-based contrast agents. We present novel DWI findings following a planned partial HIFU ablation of a large sacral chordoma which had recurred after radiotherapy. Following HIFU, the treated tumor volume demonstrated loss of restriction on DWI correlating with photopenia on positron emission tomography. This suggests successful ablation and tumor necrosis. This novel finding may provide guidance for sequence selection when evaluating HIFU therapy for sacral chordoma and other tumor types for which contrast-enhanced magnetic resonance imaging may have limited utility.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu